Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-02

Clinical Trial Update: Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study is evaluating pitolisant for autism spectrum disorder in children and adolescents. The trial status is active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pitolisant (pitolisant)

Snippet

Sponsor: Bioprojet | Conditions: Autism Spectrum Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING